Clinical Trials Browser

Interventional × HER2-negative Breast Cancer × Paclitaxel × Clear all

NCT05275777 2025-07-25

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer

Phase 1/2 Active not recruiting

BreastOther solid neoplasm

HER2-negative Breast Cancer

NCT04576143 2021-08-12

Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer

Phase 2/3 Recruiting

HER2-negative Breast Cancer